MYLK anticorps (Middle Region)
Aperçu rapide pour MYLK anticorps (Middle Region) (ABIN953458)
Antigène
Voir toutes MYLK AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 542-570, Middle Region
-
Specificité
- This antibody recognizes human MYLK / MYLK3.
-
Purification
- Purified through a Protein A column followed by peptide affinity purification
-
Immunogène
- Synthetic peptide - KLH conjugated - corresponding to the central region (between 542-570aa) of human MLCK / MYLK3
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- MYLK (Myosin Light Chain Kinase (MYLK))
-
Autre désignation
- MLCK
-
Sujet
- Phosphorylation of cardiac myosin heavy chains (like MYH7B) and light chains (like MYL2) by a kinase, such as MYLK3, potentiates the force and rate of cross-bridge recruitment in cardiac myocytes [Chan et al., 2008, PubMed 18202317].Synonyms: MYLK3, Putative myosin light chain kinase 3
-
Poids moléculaire
- 88393 Da
-
ID gène
- 91807
-
NCBI Accession
- NP_872299
Antigène
-